1. PI3K/AKT signaling mediated by G protein‑coupled receptors is involved in neurodegenerative Parkinson's disease (Review).
   Noriko Nakano et al, 2017, Int J Mol Med CrossRef
2. The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's Disease
   Xiaoliang Li et al, 2017, Front. Pharmacol. CrossRef
3. Antidotal effects of curcumin against neurotoxic agents: An updated review
   Tahereh Farkhondeh et al, 2016, Asian Pacific Journal of Tropical Medicine CrossRef
4. Chemopreventive effects of FITOPROT against 5-fluorouracil-induced toxicity in HaCaT cells
   Edvande Xavier dos Santos Filho et al, 2017, Life Sciences CrossRef
5. Modulation of Nrf2 by Olive Oil and Wine Polyphenols and Neuroprotection
   Miriam Martínez-Huélamo et al, 2017, Antioxidants CrossRef
6. Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants
   Xiao-Yuan Mao et al, 2017, Pharmacology & Therapeutics CrossRef
7. The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases
   Sybil Obuobi et al, 2016, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
8. Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220
   Ji Ae Lee et al, 2017, Neurochemistry International CrossRef
9. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?
   Jeffrey R Liddell, 2017, Antioxidants (Basel) CrossRef
10. Bioinformatics analysis to identify possible mechanisms of action of curcumin against tea geometrid
    L. L. Zhang et al, 2017, J Appl Entomol CrossRef
11. Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma
    Chongxiang Lin et al, 2017 CrossRef
12. Health perspectives of a bioactive compound curcumin: A review
    Abdur Rauf et al, 2018, Trends in Food Science & Technology CrossRef
13. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review
    Azar Hosseini et al, 2018, Biomedicine & Pharmacotherapy CrossRef
14. ALSUntangled 44: curcumin
    Richard Bedlack, 2018, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration CrossRef
15. Curcumin mitigates axonal injury and neuronal cell apoptosis through the PERK/Nrf2 signaling pathway following diffuse axonal injury
    Tingqin Huang et al, 2018, NeuroReport CrossRef
16. Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies
    Małgorzata Kujawska et al, 2018, Nutrients CrossRef
17. Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
    Jeffrey R. Liddell et al, 2018, Neurochemistry International CrossRef
18. Cellular phenotypes as inflammatory mediators in Parkinson’s disease: Interventional targets and role of natural products
    Xu Jiang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
19. null
    Omar M. E. Abdel-Salam, 2019 CrossRef
20. Milk and Parkinson disease: Could galactose be the missing link
    Sarni Anna Rita et al, 2018, MNM CrossRef
21. SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters
    Shahram Darabi et al, 2018, Neurochem Res CrossRef
22. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
    Sita Sharan Patel et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
23. Antioxidant Effects of Curcumin in Models of Neurodegeneration, Ageing, Oxidative and NITROSATIVE Stress: A Review
    Shameemah Abrahams et al, 2019, Neuroscience CrossRef
24. Effects of Prolonged Dietary Curcumin Exposure on Skeletal Muscle Biochemical and Functional Responses of Aged Male Rats
    Candace Receno et al, 2019, IJMS CrossRef
25. Curcumin and Heme Oxygenase: Neuroprotection and Beyond
    Emanuela Mhillaj et al, 2019, IJMS CrossRef
26. null
    Pranay Srivastava et al, 2016 CrossRef
27. Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences
    Mahsa Hatami et al, 2019, EMIDDT CrossRef
28. Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
    Fiona Limanaqi et al, 2019, IJMS CrossRef
29. Protective Effects of Curcumin Ester Prodrug, Curcumin Diethyl Disuccinate against H2O2-Induced Oxidative Stress in Human Retinal Pigment Epithelial Cells: Potential Therapeutic Avenues for Age-Related Macular Degeneration
    Chawanphat Muangnoi et al, 2019, IJMS CrossRef
30. Curcumin protects against methylmercury-induced cytotoxicity in primary rat astrocytes by activating the Nrf2/ARE pathway independently of PKCδ
    Bobo Yang et al, 2019, Toxicology CrossRef
31. A Cleaning Crew: The Pursuit of Autophagy in Parkinson’s Disease
    Pathik Parekh et al, 2019, ACS Chem. Neurosci. CrossRef
32. Curcumin Protects Human Umbilical Vein Endothelial Cells against H2O2-Induced Cell Injury
    Jipeng Ouyang et al, 2019, Pain Research and Management CrossRef
33. The bright side of plasmonic gold nanoparticles; activation of Nrf2, the cellular protective pathway
    Alona Goldstein et al, 2016, Nanoscale CrossRef
34. Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson’s Disease
    Yan-Hua Li et al, 2017, Mol Neurobiol CrossRef
35. Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols
    Marjan Ajami et al, 2017, Neuroscience & Biobehavioral Reviews CrossRef
36. Highly bioavailable curcumin powder suppresses articular cartilage damage in rats with mono-iodoacetate (MIA)-induced osteoarthritis
    Hyun-Ji Park et al, 2019, Food Sci Biotechnol CrossRef
37. Curcumin, Hormesis and the Nervous System
    Maria Concetta Scuto et al, 2019, Nutrients CrossRef
38. Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
    Qi Li et al, 2019, European Journal of Medicinal Chemistry CrossRef
39. null
    Pablo Vicente Torres-Ortega et al, 2019 CrossRef
40. Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain
    Małgorzata Kujawska et al, 2019, IJMS CrossRef
41. Curcumin supplementation shows modulatory influence on functional and morphological features of hippocampus in mice subjected to arsenic trioxide exposure
    Kamakshi Mehta et al, 2020, Anat Cell Biol CrossRef
42. null
    Magisetty Obulesu, 2020 CrossRef
43. Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury
    Milad Ashrafizadeh et al, 2020, CMM CrossRef
44. Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration
    Francesco Di Meo et al, 2020, IJMS CrossRef
45. Effect of Curcumin on Protein Damage Induced by Rotenone in Dopaminergic PC12 Cells
    Sandra Buratta et al, 2020, IJMS CrossRef
46. DJ-1 alleviates anoxia and hypoglycemia injury in cardiac microvascular via AKT and GSH
    Jia Wang et al, 2020, Molecular and Cellular Probes CrossRef
47. Ruta graveolens as a potential source of neuroactive compounds to promote and restore neural functions
    Luca Colucci-D’Amato et al, 2020, Journal of Traditional and Complementary Medicine CrossRef
48. Sevoflurane preconditioning inhibits cardiomyocyte injury induced by oxygen‑glucose deprivation by modulating TXNIP
    Meina Ma et al, 2020, Int J Mol Med CrossRef
49. Antioxidant Defense Mechanisms and its Dysfunctional Regulation in the Mitochondrial Disease, Friedreich’s Ataxia
    S. Chiang et al, 2020, Free Radical Biology and Medicine CrossRef
50. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson’s disease
    Bianca Marchetti, 2020, Redox Biology CrossRef
51. Curcumin and hesperetin attenuate D-galactose-induced brain senescence in vitro and in vivo
    Jihye Lee et al, 2020, Nutr Res Pract CrossRef
52. Merging the Multi-Target Effects of Phytochemicals in Neurodegeneration: From Oxidative Stress to Protein Aggregation and Inflammation
    Fiona Limanaqi et al, 2020, Antioxidants CrossRef
53. Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson's disease in rotenone-treated rats
    Dina M. Monir et al, 2020, Behav Brain Funct CrossRef
54. p62-Nrf2-p62 Mitophagy Regulatory Loop as a Target for Preventive Therapy of Neurodegenerative Diseases
    Artem P. Gureev et al, 2020, Brain Sciences CrossRef
55. A Mechanistic Evaluation of Antioxidant Nutraceuticals on Their Potential against Age-Associated Neurodegenerative Diseases
    Nur Zuliani Ramli et al, 2020, Antioxidants CrossRef
56. Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders
    Elisa Panzarini et al, 2020, Nanomaterials CrossRef
57. null
    Magisetty Obulesu, 2021 CrossRef
58. Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson’s Disease Rat Model
    Hany H. Arab et al, 2021, ACS Chem. Neurosci. CrossRef
59. Food-Derived Pharmacological Modulators of the Nrf2/ARE Pathway: Their Role in the Treatment of Diseases
    Feijie Zhao et al, 2021, Molecules CrossRef
60. A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases
    Serena Silvestro et al, 2021, IJMS CrossRef
61. Nrf2 as a potential target for Parkinson’s disease therapy
    Yingcai Niu et al, 2021, J Mol Med CrossRef
62. PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
    Hui-Zhi Long et al, 2021, Front. Pharmacol. CrossRef
63. Curcumin activates Nrf2 through PKCδ-mediated p62 phosphorylation at Ser351
    Jee-Yun Park et al, 2021, Sci Rep CrossRef
64. Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington’s Disease
    Samar M. Shawki et al, 2021, Front. Pharmacol. CrossRef
65. Nrf2 Regulation by Curcumin: Molecular Aspects for Therapeutic Prospects
    Seyed Hossein Shahcheraghi et al, 2021, Molecules CrossRef
66. Nrf2-Related Therapeutic Effects of Curcumin in Different Disorders
    Soudeh Ghafouri-Fard et al, 2022, Biomolecules CrossRef
67. Circulating (Poly)phenol Metabolites: Neuroprotection in a 3D Cell Model of Parkinson's Disease
    Rafael Carecho et al, 2022, Molecular Nutrition Food Res CrossRef
68. Protective effect of curcumin against rotenone-induced substantia nigra pars compacta neuronal dysfunction
    L. V. Darbinyan et al, 2022, Metab Brain Dis CrossRef
69. From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview
    Wolf-Dieter Rausch et al, 2022, J Neural Transm CrossRef
70. Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions
    Chenyin Wang et al, 2022, Front. Pharmacol. CrossRef
71. The Anti-Parkinson Potential of Gingko biloba-Supplement Mitigates Cortico-Cerebellar Degeneration and Neuropathobiological Alterations via Inflammatory and Apoptotic Mediators in Mice
    Olusegun G. Adebayo et al, 2022, Neurochem Res CrossRef
72. Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Role of Curcumin, Dopamine Agonist and Adenosine A2A Receptor Antagonist
    Asmaa Fathy Aboul Naser et al, 2022, CAS CrossRef
73. Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial
    Hamidreza Ghodsi et al, 2022, Clinical Neurology and Neurosurgery CrossRef
74. The Functional Roles of Curcumin on Astrocytes in Neurodegenerative Diseases.
    Amir Mohammadi et al, 2022, Neuroimmunomodulation CrossRef
75. Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?
    Alexander Leathem et al, 2022, IJMS CrossRef
76. Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways
    Priyanka Joshi et al, 2022, Phytotherapy Research CrossRef
77. GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders
    Divya Soni et al, 2022, Pharmacol. Rep CrossRef
78. A critical analysis on the concentrations of phenolic compounds tested using in vitro and in vivo Parkinson’s disease models
    José Messias Perdigão et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
79. Design, synthesis and evaluation of monoketene compounds as novel potential Parkinson disease agents by suppressing ER stress via AKT
    Jun Chen et al, 2023, Bioorganic Chemistry CrossRef
80. Analysis of phenolic compounds in Parkinson’s disease: a bibliometric assessment of the 100 most cited papers
    José Messias Perdigão et al, 2023, Front. Aging Neurosci. CrossRef
81. null
    Adnan Khan et al, 2023 CrossRef
82. Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants
    Jin Feng et al, 2023, Acta Pharmaceutica Sinica B CrossRef
83. Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology
    Rubina Roy et al, 2023, ACS Chem. Neurosci. CrossRef
84. Dietary flavonoids may have a protective and therapeutic effect in Parkinson's disease: A systematic review
    González-May Christian Adrián et al, 2023, Nutrition Research CrossRef
85. The Effects of Curcumin on Astrocytes in Common Neurodegenerative Conditions
    Ameer A. Alameri et al, 2023, MRMC CrossRef